The Patent Finder

Terms ending in 2030

Runway Advisors, LLC

Every in-force patent on Runway Advisors, LLC's record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,895,436Vaccines Against Herpes Simplex Virus Type 2: Compositions and Methods for Eliciting an Immune Response
In force
 · High confidence
Runway Advisors, LLCIn forceHigh confidence
US 10,653,771Vaccines Against Herpes Simplex Virus Type 2: Compositions and Methods for Eliciting an Immune Response
In force (reinstated)
 · High confidence
Runway Advisors, LLCIn force (reinstated)High confidence
US 8,617,564Vaccines Against Herpes Simplex Virus Type 2: Compositions and Methods for Eliciting an Immune Response
In force
 · High confidence
Runway Advisors, LLCIn forceHigh confidence
3 of 3 patents shown. Soonest term end first, then patent number.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited